Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bridget J. Anderson is active.

Publication


Featured researches published by Bridget J. Anderson.


Clinical Infectious Diseases | 2004

Risk Factors for Sporadic Campylobacter Infection in the United States: A Case-Control Study in FoodNet Sites

Cindy R. Friedman; Robert M. Hoekstra; Michael C. Samuel; Ruthanne Marcus; Jeffrey B. Bender; Beletshachew Shiferaw; Sudha Reddy; Shama D. Ahuja; Debra L. Helfrick; Felicia P. Hardnett; Michael A. Carter; Bridget J. Anderson; Robert V. Tauxe

Campylobacter is a common cause of gastroenteritis in the United States. We conducted a population-based case-control study to determine risk factors for sporadic Campylobacter infection. During a 12-month study, we enrolled 1316 patients with culture-confirmed Campylobacter infections from 7 states, collecting demographic, clinical, and exposure data using a standardized questionnaire. We interviewed 1 matched control subject for each case patient. Thirteen percent of patients had traveled abroad. In multivariate analysis of persons who had not traveled, the largest population attributable fraction (PAF) of 24% was related to consumption of chicken prepared at a restaurant. The PAF for consumption of nonpoultry meat that was prepared at a restaurant was also large (21%); smaller proportions of illness were associated with other food and nonfood exposures. Efforts to reduce contamination of poultry with Campylobacter should benefit public health. Restaurants should improve food-handling practices, ensure adequate cooking of meat and poultry, and consider purchasing poultry that has been treated to reduce Campylobacter contamination.


Clinical Infectious Diseases | 2007

Listeria monocytogenes Infection from Foods Prepared in a Commercial Establishment: A Case-Control Study of Potential Sources of Sporadic Illness in the United States

Jay K. Varma; Michael C. Samuel; Ruthanne Marcus; Robert M. Hoekstra; Carlota Medus; Suzanne Segler; Bridget J. Anderson; Timothy F. Jones; Beletshachew Shiferaw; Nicole Haubert; Melanie Megginson; Patrick V. McCarthy; Lewis M. Graves; Thomas Van Gilder; Frederick J. Angulo

BACKGROUND Listeria monocytogenes has been estimated to cause >2500 illnesses and 500 deaths annually in the United States. Efforts to reduce foodborne listeriosis have focused on foods frequently implicated in outbreaks. Potential sources for L. monocytogenes infection not associated with outbreaks remain poorly understood. METHODS The Foodborne Diseases Active Surveillance Network conducts surveillance for culture-confirmed listeriosis at clinical laboratories in 9 states. After excluding outbreak-associated cases, we attempted to enroll eligible case patients with L. monocytogenes infection in a case-control study from 2000 through 2003. Control subjects were recruited through health care providers and were matched to case patients by state, age, and immunosuppression status. Data were collected about exposures occurring in the 4 weeks before specimen collection from the case patients. RESULTS Of the 249 case patients with L. monocytogenes infection, only 12 (5%) had cases that were associated with outbreaks; 6 other patients were ineligible for other reasons. Of 231 eligible case patients, 169 (73%) were enrolled in the study. We classified 28 case patients as having pregnancy-associated cases. We enrolled 376 control subjects. In multivariable analysis, L. monocytogenes infection was associated with eating melons at a commercial establishment (odds ratio, 2.6; 95% confidence interval, 1.4-5.0) and eating hummus prepared in a commercial establishment (odds ratio, 5.7; 95% confidence interval, 1.7-19.1). CONCLUSIONS Most cases of L. monocytogenes infection were not associated with outbreaks. Reducing the burden of foodborne listeriosis may require interventions directed at retail environments and at foods, such as melons and hummus, that are not commonly recognized as high risk. Because of the severity of listeriosis, pregnant women and other persons at risk may wish to avoid eating these newly implicated foods.


The Journal of Infectious Diseases | 2006

Highly resistant Salmonella Newport-MDRAmpC transmitted through the domestic US food supply: a FoodNet case-control study of sporadic Salmonella Newport infections, 2002-2003.

Jay K. Varma; Ruthanne Marcus; Sara A. Stenzel; Samir Hanna; Sharmeen Gettner; Bridget J. Anderson; Tameka Hayes; Beletshachew Shiferaw; Tessa L. Crume; Kevin Joyce; Kathleen E. Fullerton; Andrew C. Voetsch; Frederick J. Angulo

BACKGROUND A new multidrug-resistant (MDR) strain of Salmonella serotype Newport, Newport-MDRAmpC, has recently emerged. We sought to identify the medical, behavioral, and dietary risk factors for laboratory-confirmed Salmonella Newport infection, including that with Newport-MDRAmpC. METHODS A 12-month population-based case-control study was conducted during 2002-2003 in 8 sites of the Foodborne Diseases Active Surveillance Network (FoodNet), with 215 case patients with Salmonella Newport infection and 1154 healthy community control subjects. RESULTS Case patients with Newport-MDRAmpC infection were more likely than control subjects to have taken an antimicrobial agent to which Newport-MDRAmpC is resistant during the 28 days before the onset of diarrheal illness (odds ratio [OR], 5.0 [95% confidence interval {CI}, 1.6-16]). Case patients with Newport-MDRAmpC infection were also more likely to have eaten uncooked ground beef (OR, 7.8 [95% CI, 1.4-44]) or runny scrambled eggs or omelets prepared in the home (OR, 4.9 [95% CI, 1.3-19]) during the 5 days before the onset of illness. International travel was not a risk factor for Newport-MDRAmpC infection but was a strong risk factor for pansusceptible Salmonella Newport infection (OR, 7.1 [95% CI, 2.0-24]). Case patients with pansusceptible infection were also more likely to have a frog or lizard in their household (OR, 2.9 [95% CI, 1.1-7.7]). CONCLUSIONS Newport-MDRAmpC infection is acquired through the US food supply, most likely from bovine and, perhaps, poultry sources, particularly among persons already taking antimicrobial agents.


Clinical Infectious Diseases | 2007

Reduction in the Incidence of Invasive Listeriosis in Foodborne Diseases Active Surveillance Network Sites, 1996-2003

Andrew C. Voetsch; Frederick J. Angulo; Timothy F. Jones; Matthew R. Moore; Celine Nadon; Patrick McCarthy; Beletshachew Shiferaw; Melanie Megginson; Sharon Hurd; Bridget J. Anderson; Alicia Cronquist; Duc J. Vugia; Carlota Medus; Suzanne Segler; Lewis M. Graves; Robert M. Hoekstra; Patricia M. Griffin

BACKGROUND Listeriosis is a leading cause of death among patients with foodborne diseases in the United States. Monitoring disease incidence is an important element of listeriosis surveillance and control. METHOD We conducted population-based surveillance for Listeria monocytogenes isolates obtained from normally sterile sites at all clinical diagnostic laboratories in the Foodborne Diseases Active Surveillance Network from 1996 through 2003. RESULTS The incidence of laboratory-confirmed invasive listeriosis decreased by 24% from 1996 through 2003; pregnancy-associated disease decreased by 37%, compared with a decrease of 23% for patients > or =50 years old. The highest incidence was reported among Hispanic persons from 1997 through 2001. Differences in incidence by age group and ethnicity may be explained by dietary preferences. CONCLUSION The marked decrease in the incidence of listeriosis may be related to the decrease in the prevalence of L. monocytogenes contamination of ready-to-eat foods since 1996. The crude incidence in 2003 of 3.1 cases per 1 million population approaches the governments Healthy People objective of 2.5 cases per 1 million population by 2005. Further decreases in listeriosis incidence will require continued efforts of industry and government to reduce contamination of food and continued efforts to educate consumers and clinicians.


Pediatrics | 2006

A Case-Control Study of the Epidemiology of Sporadic Salmonella Infection in Infants

Timothy F. Jones; L. Amanda Ingram; Kathleen E. Fullerton; Ruthanne Marcus; Bridget J. Anderson; Patrick V. McCarthy; Duc J. Vugia; Beletshachew Shiferaw; Nicole Haubert; Stephanie Wedel; Frederick J. Angulo

OBJECTIVE. Rates of Salmonella infection are highest in infants, but little is known about potential sources of infection in this high-risk population. We performed a case-control study to identify dietary and environmental risk factors for sporadic salmonellosis among infants. PATIENTS AND METHODS. In 2002–2004, the Foodborne Diseases Active Surveillance Network conducted a population-based, case-control study of sporadic salmonellosis among infants <1 year of age in 8 states. Cases were identified via active laboratory-based surveillance. Healthy controls were frequency matched by age and identified through birth registries or published birth announcements. We assessed diet and environmental exposures in the 5 days before illness onset or interview. Data were analyzed by using logistic regression adjusting for age. RESULTS. The study enrolled 442 subjects and 928 controls. Compared with healthy controls, infants with Salmonella infection were less likely to have been breastfed and more likely to have had exposure to reptiles, to have ridden in a shopping cart next to meat or poultry, or to have consumed concentrated liquid infant formula during the 5-day exposure period. Travel outside the United States was associated with illness in infants 3 to 6 and >6 months of age. Attending day care with a child with diarrhea was associated with salmonellosis in infants >6 months of age. CONCLUSIONS. We identified a number of modifiable protective and risk factors for salmonellosis in infants. Attention should be directed at developing effective preventive measures for this high-risk population.


Pediatric Infectious Disease Journal | 2007

Sporadic Campylobacter infection in infants : A population-based surveillance case-control study

Kathleen E. Fullerton; L. Amanda Ingram; Timothy F. Jones; Bridget J. Anderson; Patrick V. McCarthy; Sharon Hurd; Beletshachew Shiferaw; Duc J. Vugia; Nicole Haubert; Tameka Hayes; Stephanie Wedel; Elaine Scallan; Olga L. Henao; Frederick J. Angulo

Background: Campylobacter is an important cause of foodborne illness in infants (younger than 1 year of age), but little is known about the sources of infection in this age group. Methods: Eight sites in the Foodborne Diseases Active Surveillance Network (FoodNet) participated in a 24-month population-based case-control study conducted in 2002–2004. Cases were infants with laboratory-confirmed Campylobacter infection ascertained through active laboratory surveillance, and controls were infants in the community. Results: We enrolled 123 cases and 928 controls. Infants 0–6 months of age with Campylobacter infection were less likely to be breast-fed than controls [odds ratio (OR); 0.2; 95% confidence interval (CI), 0.1–0.6]. Risk factors for infants 0–6 months of age included drinking well water (OR 4.4; CI, 1.4–14) and riding in a shopping cart next to meat or poultry (OR 4.0; CI, 1.2–13.0). Risk factors for infants 7–11 months of age included visiting or living on a farm (OR 6.2; CI, 2.2–17), having a pet with diarrhea in the home (OR 7.6; CI, 2.1–28) and eating fruits and vegetables prepared in the home (OR 2.5, CI 1.2–4.9). Campylobacter infection was associated with travel outside the United States at all ages (OR 19.3; CI, 4.5–82.1). Conclusions: Several unique protective and risk factors were identified among infants, and these risk factors vary by age, suggesting that prevention measures be targeted accordingly. Breast-feeding was protective for the youngest infants and should continue to be encouraged.


Clinical Infectious Diseases | 2016

Willingness to Take, Use of, and Indications for Pre-exposure Prophylaxis Among Men Who Have Sex With Men-20 US Cities, 2014.

Brooke Hoots; Teresa Finlayson; Lina Nerlander; Gabriela Paz-Bailey; Pascale M. Wortley; Jeff Todd; Kimi Sato; Colin Flynn; Danielle German; Dawn Fukuda; Rose Doherty; Chris Wittke; Nikhil Prachand; Nanette Benbow; Antonio D. Jimenez; Jonathon Poe; Shane Sheu; Alicia Novoa; Alia Al-Tayyib; Melanie Mattson; Vivian Griffin; Emily Higgins; Kathryn Macomber; Salma Khuwaja; Hafeez Rehman; Paige Padgett; Ekow Kwa Sey; Yingbo Ma; Marlene LaLota; John Mark Schacht

BACKGROUND Pre-exposure prophylaxis (PrEP) is an effective prevention tool for people at substantial risk of acquiring human immunodeficiency virus (HIV). To monitor the current state of PrEP use among men who have sex with men (MSM), we report on willingness to use PrEP and PrEP utilization. To assess whether the MSM subpopulations at highest risk for infection have indications for PrEP according to the 2014 clinical guidelines, we estimated indications for PrEP for MSM by demographics. METHODS We analyzed data from the 2014 cycle of the National HIV Behavioral Surveillance (NHBS) system among MSM who tested HIV negative in NHBS and were currently sexually active. Adjusted prevalence ratios and 95% confidence intervals were estimated from log-linked Poisson regression with generalized estimating equations to explore differences in willingness to take PrEP, PrEP use, and indications for PrEP. RESULTS Whereas over half of MSM said they were willing to take PrEP, only about 4% reported using PrEP. There was no difference in willingness to take PrEP between black and white MSM. PrEP use was higher among white compared with black MSM and among those with greater education and income levels. Young, black MSM were less likely to have indications for PrEP compared with young MSM of other races/ethnicities. CONCLUSIONS Young, black MSM, despite being at high risk of HIV acquisition, may not have indications for PrEP under the current guidelines. Clinicians may need to consider other factors besides risk behaviors such as HIV incidence and prevalence in subgroups of their communities when considering prescribing PrEP.


Clinical Infectious Diseases | 2004

Physicians as Food-Safety Educators: A Practices and Perceptions Survey

Stephanie Wong; Ruthanne Marcus; Marguerite A. Hawkins; Sue Shallow; Katherine Gibbs McCombs; Ellen Swanson; Bridget J. Anderson; Beletshachew Shiferaw; Robb Garman; Kristen Noonan; Thomas Van Gilder

An estimated 4 million bacterial foodborne illnesses occur in the United States annually. Many of these illnesses can be prevented by educating the public about food-safety practices. We investigated both the role of physicians as food-safety educators and the barriers to providing food-safety information. Participants were randomly selected physicians (n=3117) practicing within the surveillance area of the Foodborne Diseases Active Surveillance Network; 1100 were included in the study. Although only 331 (30%) of 1110 respondents provided food-safety information to their patients, 524 (68%) of 769 who did not provide information expressed interest in doing so. Physicians were more likely to provide food-safety information to patients if they perceived foodborne disease to be a serious problem, perceived food-safety education as their role, felt that patients perceived them as a valuable resource for food-safety advice, or felt comfortable making food-safety recommendations. A national physician education campaign that addresses barriers in food-safety education could improve food-safety education by physicians.


PLOS ONE | 2012

Transmitted Antiretroviral Drug Resistance in New York State, 2006-2008: Results from a New Surveillance System

Adam C. Readhead; Daniel E. Gordon; Zhengyan Wang; Bridget J. Anderson; Kathleen S. Brousseau; Maria A. Kouznetsova; Lisa A. Forgione; Lou C. Smith; Lucia V. Torian

Background HIV transmitted drug resistance (TDR) is a public health concern because it has the potential to compromise antiretroviral therapy (ART) at the population level. In New York State, high prevalence of TDR in a local cohort and a multiclass resistant case cluster led to the development and implementation of a statewide resistance surveillance system. Methodology We conducted a cross-sectional analysis of the 13,109 cases of HIV infection that were newly diagnosed and reported in New York State between 2006 and 2008, including 4,155 with HIV genotypes drawn within 3 months of initial diagnosis and electronically reported to the new resistance surveillance system. We assessed compliance with DHHS recommendations for genotypic resistance testing and estimated TDR among new HIV diagnoses. Principal Findings Of 13,109 new HIV diagnoses, 9,785 (75%) had laboratory evidence of utilization of HIV-related medical care, and 4,155 (43%) had a genotype performed within 3 months of initial diagnosis. Of these, 11.2% (95% confidence interval [CI], 10.2%–12.1%) had any evidence of TDR. The proportion with mutations associated with any antiretroviral agent in the NNRTI, NRTI or PI class was 6.3% (5.5%–7.0%), 4.3% (3.6%–4.9%) and 2.9% (2.4%–3.4%), respectively. Multiclass resistance was observed in <1%. TDR did not increase significantly over time (p for trend = 0.204). Men who have sex with men were not more likely to have TDR than persons with heterosexual risk factor (OR 1.0 (0.77–1.30)). TDR to EFV+TDF+FTC and LPV/r+TDF+FTC regimens was 7.1% (6.3%–7.9%) and 1.4% (1.0%–1.8%), respectively. Conclusions/Significance TDR appears to be evenly distributed and stable among new HIV diagnoses in New York State; multiclass TDR is rare. Less than half of new diagnoses initiating care received a genotype per DHHS guidelines.


PLOS ONE | 2015

Early Linkage to HIV Care and Antiretroviral Treatment among Men Who Have Sex with Men — 20 Cities, United States, 2008 and 2011

Brooke Hoots; Teresa Finlayson; Cyprian Wejnert; Gabriela Paz-Bailey; Jennifer Taussig; Robert Gern; Tamika Hoyte; Laura Teresa Hernandez Salazar; Jianglan White; Jeff Todd; Greg Bautista; Colin Flynn; Frangiscos Sifakis; Danielle German; Debbie Isenberg; Maura Driscoll; Elizabeth Hurwitz; Miminos; Rose Doherty; Chris Wittke; Nikhil Prachand; Nanette Benbow; Sharon Melville; Praveen Pannala; Richard Yeager; Aaron Sayegh; Jim Dyer; Shane Sheu; Alicia Novoa; Mark Thrun

Early linkage to care and antiretroviral (ARV) treatment are associated with reduced HIV transmission. Male-to-male sexual contact represents the largest HIV transmission category in the United States; men who have sex with men (MSM) are an important focus of care and treatment efforts. With the release of the National HIV/AIDS Strategy and expanded HIV treatment guidelines, increases in early linkage to care and ARV treatment are expected. We examined differences in prevalence of early linkage to care and ARV treatment among HIV-positive MSM between 2008 and 2011. Data are from the National HIV Behavioral Surveillance System, which monitors behaviors among populations at high risk of HIV infection in 20 U.S. cities with high AIDS burden. MSM were recruited through venue-based, time-space sampling. Prevalence ratios comparing 2011 to 2008 were estimated using linear mixed models. Early linkage was defined as an HIV clinic visit within 3 months of diagnosis. ARV treatment was defined as use at interview. Prevalence of early linkage to care was 79% (187/236) in 2008 and 83% (241/291) in 2011. In multivariable analysis, prevalence of early linkage did not differ significantly between years overall (P = 0.44). Prevalence of ARV treatment was 69% (790/1,142) in 2008 and 79% (1,049/1,336) in 2001. In multivariable analysis, ARV treatment increased overall (P = 0.0003) and among most sub-groups. Black MSM were less likely than white MSM to report ARV treatment (P = 0.01). While early linkage to care did not increase significantly between 2008 and 2011, ARV treatment increased among most sub-groups. Progress is being made in getting MSM on HIV treatment, but more efforts are needed to decrease disparities in ARV coverage.

Collaboration


Dive into the Bridget J. Anderson's collaboration.

Top Co-Authors

Avatar

Beletshachew Shiferaw

Oregon Department of Human Services

View shared research outputs
Top Co-Authors

Avatar

Frederick J. Angulo

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Lou C. Smith

New York State Department of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel E. Gordon

New York State Department of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Duc J. Vugia

California Department of Public Health

View shared research outputs
Top Co-Authors

Avatar

Kathleen E. Fullerton

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Patrick V. McCarthy

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Carol-Ann Swain

New York State Department of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge